Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

New phase II study investigates Tarceva in poor performance NSCLC patients

March 23, 2004

Chiron discontinues development of tezacitabine

March 23, 2004

Pharmacia describes new protein kinase inhibitors, their preparation and use

March 22, 2004

GTx enters collaboration and license agreement with Ortho Biotech for andarine

March 22, 2004

Greater prevention of breast cancer recurrence with exemestane

March 22, 2004

Recombinant immunotoxins against breast cancer, osteosarcoma and neuroblastoma

March 22, 2004

Corgenix Medical and Genesis Bioventures sign merger agreement

March 19, 2004

Maxim reacquires rights to MX-2105 series

March 19, 2004

Novel antiangiogenic tyrosine kinase inhibitor claimed by Boehringer Ingelheim

March 19, 2004

Launch of new Salagen dosage

March 19, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 26, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 27, 2026.
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Muted and missing M&As: JPM deals absent in 2026
BioWorld
For years, the J.P. Morgan Healthcare Conference (JPM) kicked off with splashy headlines of major M&A activity among biopharma companies, but in 2026, the hype...
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...